FDA nod fuels Filament’s psychedelics push, but cash running short
The firm could have roughly a year's runway remaining based on the first-quarter burn rate. A key regulatory green light cleared the way for Filament Health Corp.’s (OTCQB: FLHLF) lead psychedelics program in the latest first quarter as cash levels …